Medicines Co. Gets Fed. Circ. Grilling On Blood Thinner IP
Members of a Federal Circuit panel questioned whether The Medicines Co. could hold onto one of its patents on the blood thinning drug Angiomax Tuesday, wondering whether the patent was so...To view the full article, register now.
Already a subscriber? Click here to view full article